Biopharmaceutical benchmarks 2022.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36471135.
- Also identified by DOI 10.1038/s41587-022-01582-x and PMC identifier 9735008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Monoclonal antibodies as a group continue to lead biopharmaceuticals in numbers of approvals and sales, although COVID-19 vaccines shot to the top of the list of highest-grossing individual products.
Medical subject headings
- Biological Products